Authors' reply concerning the letter by Ensminger et al.

about

Authors' reply concerning the letter by Ensminger et al.

Item

http://www.wikidata.org/entity/Q40562358

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Authors' reply concerning the letter by Ensminger et al.

@en

type

Item

label

Authors' reply concerning the letter by Ensminger et al.

@en

prefLabel

Authors' reply concerning the letter by Ensminger et al.

@en

P1476

Authors' reply concerning the letter by Ensminger et al.

@en

P2093

Axel Kiwi

http://www.w3.org/2001/XMLSchema#string

Bruno Reichart

http://www.w3.org/2001/XMLSchema#string

Christian Hagl

http://www.w3.org/2001/XMLSchema#string

Gerhard Steinbeck

http://www.w3.org/2001/XMLSchema#string

Michael Weis

http://www.w3.org/2001/XMLSchema#string

Rene Schramm

http://www.w3.org/2001/XMLSchema#string

Steffen Massberg

http://www.w3.org/2001/XMLSchema#string

Tassilo Hübner

http://www.w3.org/2001/XMLSchema#string

Thomas Nickel

http://www.w3.org/2001/XMLSchema#string

P2860

Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond

Inotropes.

Intermittent positive inotrope infusion in the management of end-stage, low-output heart failure.

Inotropic therapy for heart failure: an evidence-based approach.

The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis.

Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure

Management of end stage heart failure

Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomised trials.

A single German center experience with intermittent inotropes for patients on the high-urgent heart transplant waiting list.

Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure.

P2888

s00392-015-0908-2

P304

1000-1002

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00392-015-0908-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26349784

http://www.w3.org/2001/XMLSchema#string